The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Sodium Iodine (131I) Drugs Market Research Report 2024
Synopsis
Sodium iodide I 131 is used to treat hyperthyroidism (an overactive thyroid) and certain kinds of thyroid cancer. This medicine is taken up mainly by the thyroid gland.
Global Sodium Iodine (131I) Drugs market is projected to reach US$ 43 million in 2029, increasing from US$ 27 million in 2022, with the CAGR of 6.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium Iodine (131I) Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sodium Iodine (131I) Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Jubilant Radiopharma
AnazaoHealth
International Isotopes
Bracco
Mallinckrodt
Hta Co., Ltd
Yantai Dongcheng Biochemicals Co.,Ltd.
Chengdu Gaotong Isotope Co.,Ltd.
BWXT Medical Ltd
Segment by Type
Sodium Iodine [131I] Capsules
Sodium iodine [131I] Oral Solution
Segment by Application
Diagnosis and Investigation
Hyperthyroidism
Thyroid Cancer
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium Iodine (131I) Drugs report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Sodium iodide I 131 is used to treat hyperthyroidism (an overactive thyroid) and certain kinds of thyroid cancer. This medicine is taken up mainly by the thyroid gland.
Global Sodium Iodine (131I) Drugs market is projected to reach US$ 43 million in 2029, increasing from US$ 27 million in 2022, with the CAGR of 6.6% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Sodium Iodine (131I) Drugs market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Sodium Iodine (131I) Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Jubilant Radiopharma
AnazaoHealth
International Isotopes
Bracco
Mallinckrodt
Hta Co., Ltd
Yantai Dongcheng Biochemicals Co.,Ltd.
Chengdu Gaotong Isotope Co.,Ltd.
BWXT Medical Ltd
Segment by Type
Sodium Iodine [131I] Capsules
Sodium iodine [131I] Oral Solution
Segment by Application
Diagnosis and Investigation
Hyperthyroidism
Thyroid Cancer
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Sodium Iodine (131I) Drugs report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Sodium Iodine (131I) Drugs Market Overview
1.1 Product Overview and Scope of Sodium Iodine (131I) Drugs
1.2 Sodium Iodine (131I) Drugs Segment by Type
1.2.1 Global Sodium Iodine (131I) Drugs Market Value Comparison by Type (2023-2029)
1.2.2 Sodium Iodine [131I] Capsules
1.2.3 Sodium iodine [131I] Oral Solution
1.3 Sodium Iodine (131I) Drugs Segment by Application
1.3.1 Global Sodium Iodine (131I) Drugs Market Value by Application: (2023-2029)
1.3.2 Diagnosis and Investigation
1.3.3 Hyperthyroidism
1.3.4 Thyroid Cancer
1.4 Global Sodium Iodine (131I) Drugs Market Size Estimates and Forecasts
1.4.1 Global Sodium Iodine (131I) Drugs Revenue 2018-2029
1.4.2 Global Sodium Iodine (131I) Drugs Sales 2018-2029
1.4.3 Global Sodium Iodine (131I) Drugs Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Sodium Iodine (131I) Drugs Market Competition by Manufacturers
2.1 Global Sodium Iodine (131I) Drugs Sales Market Share by Manufacturers (2018-2023)
2.2 Global Sodium Iodine (131I) Drugs Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Sodium Iodine (131I) Drugs Average Price by Manufacturers (2018-2023)
2.4 Global Sodium Iodine (131I) Drugs Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Sodium Iodine (131I) Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sodium Iodine (131I) Drugs, Product Type & Application
2.7 Sodium Iodine (131I) Drugs Market Competitive Situation and Trends
2.7.1 Sodium Iodine (131I) Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Sodium Iodine (131I) Drugs Players Market Share by Revenue
2.7.3 Global Sodium Iodine (131I) Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Sodium Iodine (131I) Drugs Retrospective Market Scenario by Region
3.1 Global Sodium Iodine (131I) Drugs Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Sodium Iodine (131I) Drugs Global Sodium Iodine (131I) Drugs Sales by Region: 2018-2029
3.2.1 Global Sodium Iodine (131I) Drugs Sales by Region: 2018-2023
3.2.2 Global Sodium Iodine (131I) Drugs Sales by Region: 2024-2029
3.3 Global Sodium Iodine (131I) Drugs Global Sodium Iodine (131I) Drugs Revenue by Region: 2018-2029
3.3.1 Global Sodium Iodine (131I) Drugs Revenue by Region: 2018-2023
3.3.2 Global Sodium Iodine (131I) Drugs Revenue by Region: 2024-2029
3.4 North America Sodium Iodine (131I) Drugs Market Facts & Figures by Country
3.4.1 North America Sodium Iodine (131I) Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Sodium Iodine (131I) Drugs Sales by Country (2018-2029)
3.4.3 North America Sodium Iodine (131I) Drugs Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sodium Iodine (131I) Drugs Market Facts & Figures by Country
3.5.1 Europe Sodium Iodine (131I) Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Sodium Iodine (131I) Drugs Sales by Country (2018-2029)
3.5.3 Europe Sodium Iodine (131I) Drugs Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sodium Iodine (131I) Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Sodium Iodine (131I) Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Sodium Iodine (131I) Drugs Sales by Country (2018-2029)
3.6.3 Asia Pacific Sodium Iodine (131I) Drugs Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sodium Iodine (131I) Drugs Market Facts & Figures by Country
3.7.1 Latin America Sodium Iodine (131I) Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Sodium Iodine (131I) Drugs Sales by Country (2018-2029)
3.7.3 Latin America Sodium Iodine (131I) Drugs Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sodium Iodine (131I) Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Sodium Iodine (131I) Drugs Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Sodium Iodine (131I) Drugs Sales by Country (2018-2029)
3.8.3 Middle East and Africa Sodium Iodine (131I) Drugs Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sodium Iodine (131I) Drugs Sales by Type (2018-2029)
4.1.1 Global Sodium Iodine (131I) Drugs Sales by Type (2018-2023)
4.1.2 Global Sodium Iodine (131I) Drugs Sales by Type (2024-2029)
4.1.3 Global Sodium Iodine (131I) Drugs Sales Market Share by Type (2018-2029)
4.2 Global Sodium Iodine (131I) Drugs Revenue by Type (2018-2029)
4.2.1 Global Sodium Iodine (131I) Drugs Revenue by Type (2018-2023)
4.2.2 Global Sodium Iodine (131I) Drugs Revenue by Type (2024-2029)
4.2.3 Global Sodium Iodine (131I) Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Sodium Iodine (131I) Drugs Price by Type (2018-2029)
5 Segment by Application
5.1 Global Sodium Iodine (131I) Drugs Sales by Application (2018-2029)
5.1.1 Global Sodium Iodine (131I) Drugs Sales by Application (2018-2023)
5.1.2 Global Sodium Iodine (131I) Drugs Sales by Application (2024-2029)
5.1.3 Global Sodium Iodine (131I) Drugs Sales Market Share by Application (2018-2029)
5.2 Global Sodium Iodine (131I) Drugs Revenue by Application (2018-2029)
5.2.1 Global Sodium Iodine (131I) Drugs Revenue by Application (2018-2023)
5.2.2 Global Sodium Iodine (131I) Drugs Revenue by Application (2024-2029)
5.2.3 Global Sodium Iodine (131I) Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Sodium Iodine (131I) Drugs Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Jubilant Radiopharma
6.1.1 Jubilant Radiopharma Corporation Information
6.1.2 Jubilant Radiopharma Description and Business Overview
6.1.3 Jubilant Radiopharma Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Jubilant Radiopharma Sodium Iodine (131I) Drugs Product Portfolio
6.1.5 Jubilant Radiopharma Recent Developments/Updates
6.2 AnazaoHealth
6.2.1 AnazaoHealth Corporation Information
6.2.2 AnazaoHealth Description and Business Overview
6.2.3 AnazaoHealth Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2018-2023)
6.2.4 AnazaoHealth Sodium Iodine (131I) Drugs Product Portfolio
6.2.5 AnazaoHealth Recent Developments/Updates
6.3 International Isotopes
6.3.1 International Isotopes Corporation Information
6.3.2 International Isotopes Description and Business Overview
6.3.3 International Isotopes Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2018-2023)
6.3.4 International Isotopes Sodium Iodine (131I) Drugs Product Portfolio
6.3.5 International Isotopes Recent Developments/Updates
6.4 Bracco
6.4.1 Bracco Corporation Information
6.4.2 Bracco Description and Business Overview
6.4.3 Bracco Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bracco Sodium Iodine (131I) Drugs Product Portfolio
6.4.5 Bracco Recent Developments/Updates
6.5 Mallinckrodt
6.5.1 Mallinckrodt Corporation Information
6.5.2 Mallinckrodt Description and Business Overview
6.5.3 Mallinckrodt Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mallinckrodt Sodium Iodine (131I) Drugs Product Portfolio
6.5.5 Mallinckrodt Recent Developments/Updates
6.6 Hta Co., Ltd
6.6.1 Hta Co., Ltd Corporation Information
6.6.2 Hta Co., Ltd Description and Business Overview
6.6.3 Hta Co., Ltd Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Hta Co., Ltd Sodium Iodine (131I) Drugs Product Portfolio
6.6.5 Hta Co., Ltd Recent Developments/Updates
6.7 Yantai Dongcheng Biochemicals Co.,Ltd.
6.6.1 Yantai Dongcheng Biochemicals Co.,Ltd. Corporation Information
6.6.2 Yantai Dongcheng Biochemicals Co.,Ltd. Description and Business Overview
6.6.3 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Yantai Dongcheng Biochemicals Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
6.7.5 Yantai Dongcheng Biochemicals Co.,Ltd. Recent Developments/Updates
6.8 Chengdu Gaotong Isotope Co.,Ltd.
6.8.1 Chengdu Gaotong Isotope Co.,Ltd. Corporation Information
6.8.2 Chengdu Gaotong Isotope Co.,Ltd. Description and Business Overview
6.8.3 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Chengdu Gaotong Isotope Co.,Ltd. Sodium Iodine (131I) Drugs Product Portfolio
6.8.5 Chengdu Gaotong Isotope Co.,Ltd. Recent Developments/Updates
6.9 BWXT Medical Ltd
6.9.1 BWXT Medical Ltd Corporation Information
6.9.2 BWXT Medical Ltd Description and Business Overview
6.9.3 BWXT Medical Ltd Sodium Iodine (131I) Drugs Sales, Revenue and Gross Margin (2018-2023)
6.9.4 BWXT Medical Ltd Sodium Iodine (131I) Drugs Product Portfolio
6.9.5 BWXT Medical Ltd Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sodium Iodine (131I) Drugs Industry Chain Analysis
7.2 Sodium Iodine (131I) Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sodium Iodine (131I) Drugs Production Mode & Process
7.4 Sodium Iodine (131I) Drugs Sales and Marketing
7.4.1 Sodium Iodine (131I) Drugs Sales Channels
7.4.2 Sodium Iodine (131I) Drugs Distributors
7.5 Sodium Iodine (131I) Drugs Customers
8 Sodium Iodine (131I) Drugs Market Dynamics
8.1 Sodium Iodine (131I) Drugs Industry Trends
8.2 Sodium Iodine (131I) Drugs Market Drivers
8.3 Sodium Iodine (131I) Drugs Market Challenges
8.4 Sodium Iodine (131I) Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
